✦ LIBER ✦

1459 CLINICAL AND PATHOLOGIC FEATURES OF PROSTATE CANCER WITH PROSTATIC-SPECIFIC ANTIGEN (PSA) LESS THAN 2.5 NG/ML: A STUDY OF 209 CASES

✍ Scribed by Trinh, Quoc-Dien; Ghani, Khurshid R.; Roquero, Leonardo; Jeong, Wooju; Kryvenko, Oleksandr; Diaz, Mireya; Sukukumar, Shyam; Menon, Mani; Gupta, Nilesh

Book ID: 122497096
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 46 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.02.1953

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nadir PSA less than 0.5 ng/ml: a prognos

Nadir PSA less than 0.5 ng/ml: a prognostic factor of clinically localized prostate cancer treated with external beam radiation

✍ C. Almeras; M. Zerbib; S. Conquy; D. Amsellem; D. Saighi; J. Slama; N. Thiounn; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Percent free prostate-specific antigen (

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower

✍ Jochen Walz; Alexander Haese; Vincenzo Scattoni; Thomas Steuber; Felix K. H. Chu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

Pathologic characterization of prostate

Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0–2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?

✍ John F. Ward; George Bartsch; Thomas J. Sebo; Germar-Michael Pinggera; Michael L 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Obese African-Americans with prostate ca

Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans

✍ Arthur A. Caire; Leon Sun; Thomas J. Polascik; David M. Albala; Judd W. Moul 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

A Multicenter Study of [-2]Pro-Prostate

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

✍ Catalona, William J.; Partin, Alan W.; Sanda, Martin G.; Wei, John T.; Klee, Geo 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 195 KB

Prostate-Specific Antigen (PSA) Isoform

Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting

✍ Giorgio Guazzoni; Luciano Nava; Massimo Lazzeri; Vincenzo Scattoni; Giovanni Lug 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 473 KB